126 related articles for article (PubMed ID: 22168765)
1. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
[TBL] [Abstract][Full Text] [Related]
2. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
3. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
4. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease.
Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S
Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672
[TBL] [Abstract][Full Text] [Related]
5. DNA-based prenatal carrier detection for group A xeroderma pigmentosum in a chorionic villus sample.
Matsumoto N; Saito N; Harada N; Tanaka K; Niikawa N
Prenat Diagn; 1995 Jul; 15(7):675-7. PubMed ID: 8532631
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis of xeroderma pigmentosum and trichothiodystrophy in 76 pregnancies at risk.
Kleijer WJ; van der Sterre ML; Garritsen VH; Raams A; Jaspers NG
Prenat Diagn; 2007 Dec; 27(12):1133-7. PubMed ID: 17880036
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
9. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
[TBL] [Abstract][Full Text] [Related]
10. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of xeroderma pigmentosum and Cockayne syndrome.
Cleaver JE; Volpe JP; Charles WC; Thomas GH
Prenat Diagn; 1994 Oct; 14(10):921-8. PubMed ID: 7534923
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
13. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.
Karnpean R; Fucharoen G; Fucharoen S; Sae-ung N; Sanchaisuriya K; Ratanasiri T
Acta Haematol; 2009; 121(4):227-33. PubMed ID: 19546525
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
Negishi I; Kato G; Moriwaki S; Ishikawa O
Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
16. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
J Invest Dermatol; 1997 Sep; 109(3):306-9. PubMed ID: 9284095
[TBL] [Abstract][Full Text] [Related]
17. Three nonsense mutations responsible for group A xeroderma pigmentosum.
Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M; Ueda M; Ichihashi M
Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
[TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of beta-thalassemia in Egypt: implementing accurate high-tech methods did not reflect much on the outcome.
Elgawhary S; Elbaradie Sahar MY; Rashad WM; Mosaad M; Abdalla MA; Ezzat G; Wali YA; Elbeshlawy A
Pediatr Hematol Oncol; 2008 Sep; 25(6):541-8. PubMed ID: 18728973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
